Phase I trial of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma - GORTEC 2004–02

PURPOSE: This study sought to determine the maximum tolerated dose (MTD) of oral etoposide in combination with radiotherapy in head and neck squamous cell carcinoma (HNSCC). PATIENTS AND METHODS: Phase I, multicenter, open-labelled, non-comparative and dose escalating trial. Patients with locally ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Tao, Yungan, Bardet, Etienne, Rosine, Dominique, Rolland, Frédéric, Bompas, Emmanuelle, Daly-Schveitzer, Nicolas, Lusinchi, Antoine, Bourhis, Jean
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606353/
https://www.ncbi.nlm.nih.gov/pubmed/23445779
http://dx.doi.org/10.1186/1748-717X-8-40

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606353/
https://www.ncbi.nlm.nih.gov/pubmed/23445779
http://dx.doi.org/10.1186/1748-717X-8-40

Ejemplares similares